ARCHIVES

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

This article is from The Cancer Letter archive.

Vol. 26 No. 13 | March 31, 2000

Download PDF Visit The Full Archive

Related Articles

Clinical Education Guidelines Proposed

April 4, 1975

FPD-R Regimen Well-Tolerated, With 63 Percent Complete Response

July 29, 2011

Letter to The Editor: IOM Panel Urges Greater Integration Of Research

February 12, 1999

Pitt Criticizes NCI Stance On Repayment For Fraud Trials

September 9, 1994

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014

NCI Programs: U.S., U.K., Ireland Established Consortium For Cancer Research

October 15, 1999